Eventide Asset Management - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 170 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2021$13,592,000
-2.0%
400,000
+64.6%
0.18%
-16.0%
Q4 2020$13,868,000
+11.2%
243,0000.0%0.21%
-12.7%
Q3 2020$12,466,000
-14.1%
243,0000.0%0.24%
-22.5%
Q2 2020$14,512,000
+45.1%
243,0000.0%0.32%
-2.8%
Q1 2020$10,004,000243,0000.32%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q1 2021
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$15,385,74319.76%
Redmile Group, LLC 4,475,384$56,926,8842.71%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,897,606$87,737,5481.93%
Parkman Healthcare Partners LLC 597,403$7,598,9661.39%
Ghost Tree Capital, LLC 325,000$4,134,0001.36%
BRAIDWELL LP 3,336,221$42,436,7311.34%
AlphaCentric Advisors LLC 132,000$1,679,0400.95%
ARMISTICE CAPITAL, LLC 4,612,000$58,664,6400.90%
Sunesis Advisors, LLC 96,299$1,224,9230.87%
EcoR1 Capital, LLC 993,000$12,630,9600.43%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders